Merit Medical Systems INC Form 4 insider transactions

Merit Medical Systems Inc. President and CEO Martha Goldberg Aronson received a grant of 19,594 restricted stock units.

Merit Medical Systems Inc.'s President and CEO, Martha Goldberg Aronson, was granted 19,594 restricted stock units, vesting over three years.

Merit Medical Systems CEO Fred P. Lampropoulos exercised stock options and adjusted his beneficial ownership through tax-related share surrenders.

Merit Medical Systems Director Lynne N. Ward exercised stock options and immediately sold 3,000 shares for a significant gain.

Merit Medical Systems Director Lynne N. Ward exercised stock options and subsequently sold an equal number of common shares.

Merit Medical Systems' CFO and Treasurer, Raul Parra Jr., exercised stock options and subsequently sold a portion of the acquired shares on June 13, 2025.

Merit Medical Systems Inc. President and CEO, Fred P. Lampropoulos, reported the sale of 400 shares of common stock for $95.61 per share, executed under a Rule 10b5-1 trading plan.

Merit Medical Systems Inc.'s President and CEO, Fred P. Lampropoulos, sold 10,000 shares of common stock for approximately $95.19 per share on June 5, 2025, as part of a Rule 10b5-1 trading plan.

Merit Medical Systems' Chief Human Resources Officer, Michel J. Voigt, disclosed a gift of 55 shares of the company's common stock on June 2, 2025, as detailed in a recent SEC Form 4 filing.

Merit Medical Systems Director Michael R. McDonnell sold a total of 3,500 shares of common stock in two transactions in late May and early June 2025, pursuant to a Rule 10b5-1 trading plan.

A director at Merit Medical Systems, David Floyd, sold 3,515 shares of common stock for approximately $94.16 per share, as part of a pre-established Rule 10b5-1 trading plan.

Fred P. Lampropoulos, President and CEO of Merit Medical Systems Inc. (MMSI), sold 10,000 shares of common stock for approximately $951,200, as disclosed in a recent SEC Form 4 filing.

Merit Medical Systems Inc.'s President and CEO, Fred P. Lampropoulos, reported the sale of 20,000 shares of common stock for approximately $1.93 million, executed under a Rule 10b5-1 trading plan.

Director F. Ann Millner of Merit Medical Systems exercised stock options and sold shares under a pre-arranged 10b5-1 trading plan, while also receiving a grant of restricted stock units.

Director Thomas James Gunderson of Merit Medical Systems reports the acquisition of 2,152 restricted stock units and updates to existing stock options.

Director Lynne Ward reports acquisition of restricted stock units and holdings of stock options in Merit Medical Systems.

Director Michael R. McDonnell of Merit Medical Systems Inc. received 2,152 restricted stock units (RSUs) on May 15, 2025, which will vest on May 15, 2026, subject to continued service.

Laura S. Kaiser, a director at Merit Medical Systems, received 2,152 restricted stock units (RSUs) on May 15, 2025, under the company's 2018 Long-Term Incentive Plan.

Director David Floyd reports the acquisition of 2,152 restricted stock units in Merit Medical Systems, vesting on May 15, 2026.

Director David Floyd reports the acquisition of 2,152 restricted stock units in Merit Medical Systems, vesting on May 15, 2026.

Stephen C. Evans, a director at Merit Medical Systems, received 2,152 restricted stock units (RSUs) on May 15, 2025, under the company's 2018 Long-Term Incentive Plan.

Director Lonny J Carpenter reports the acquisition of 2,152 restricted stock units in Merit Medical Systems, vesting on May 15, 2026.

Silvia Perez, a director at Merit Medical Systems, received 2,152 restricted stock units (RSUs) on May 15, 2025, which will vest on May 15, 2026, subject to continued service.

Neil Peterson, Chief Operating Officer of Merit Medical Systems, executed stock options and sold shares according to a pre-arranged Rule 10b5-1 trading plan.

Brian G. Lloyd, Chief Legal Officer and Secretary of Merit Medical Systems, reported a gift of 4,700 common stock shares and details of existing non-qualified stock options.

Voigt Michel James, Chief Human Resources Officer of Merit Medical Systems, reports transactions involving company stock and stock options.

Fred Lampropoulos, President and CEO of Merit Medical Systems, sold a significant number of shares on March 5, 2025, according to a Form 4 filing with the SEC.

CFO Raul Parra Jr. of Merit Medical Systems exercised stock options and sold shares on March 5, 2025, according to a Form 4 filing with the SEC.

Brian G. Lloyd, Chief Legal Officer and Secretary of Merit Medical Systems, exercised stock options and sold 30,000 shares of common stock on March 5, 2025.

Neil Peterson, Chief Operating Officer of Merit Medical Systems, exercised stock options and sold 5,000 shares of common stock on March 3, 2025, according to a Form 4 filing with the SEC.